SUMMARY
OBJECTIVE: This study aimed to assess adverse maternal and perinatal outcomes in parturients undergoing labor
analgesia .
METHODS: This was a retrospective
cohort study in parturients
who underwent labor
analgesia . Parturients were categorized into three groups Group 1 (n=83)—
analgesia performed with
cervical dilatation ≤4.0 cm; Group 2 (n=82)—
analgesia performed with
cervical dilatation between 5.0 and 8.0 cm; and Group 3 (n=83)—
analgesia performed with
cervical dilatation ≥9.0 cm.
RESULTS: Analgesia in parturients with
cervical dilatation ≥9.0 cm showed a higher
prevalence and a 3.86-fold increase (OR 3.86; 95%CI 1.50-9.87; p=0.009) in the
risk of
forceps delivery.
Analgesia in parturients with
cervical dilatation ≤4.0 cm showed a higher
prevalence and a 3.31-fold increase (OR 3.31; 95%CI 1.62-6.77; p=0.0016) in the
risk of
cesarean section .
Analgesia in parturients with
cervical dilatation ≥9.0 cm was associated with a higher
prevalence of fetal
bradycardia (20.7%), a need for neonatal
oxygen therapy (6.1%), and a need for admission to a
neonatal intensive care unit (4.9%).
Analgesia in parturients with
cervical dilatation ≤4 cm was associated with a higher
prevalence of
Apgar score <7 at 1st minute (44.6%).
CONCLUSION: Performing labor
analgesia in parturients with
cervical dilatation ≤4.0 or ≥9.0 cm was associated with a higher
prevalence of adverse maternal and perinatal outcomes.